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Non-invasive ventilation (niv) is defined as the administration of positive airway pressure through an interface to 
avoid creating an invasive artificial airway through the 
trachea.1,2 It comprises various techniques, including 
continuous positive airway pressure (CPAP) and 
bilevel positive airway pressure. Over the last decade, 
the use of NIV has significantly increased in the 
paediatric population.3–5 In general, NIV holds several 
advantages over invasive mechanical ventilation and is 
associated with improved pulmonary gas exchange.1,2 
Moreover, the physiological effects of NIV reduce 
respiratory distress in children presenting with acute 
respiratory failure.6
High-flow nasal cannulae therapy (HFNCT) 
refers to the delivery of a humidified oxygen and 
gas mixture at flow rates that equal or exceed the 
patient’s inspiratory flow.7 At higher flow rates, this 
technique can generate positive end-expiratory press- 
ure, although the amount of pressure generated is 
not predictable.7–9 In addition, HFNCT has effects 
on gas conditioning, thereby reducing energy needs, 
and is associated with anatomical dead space washout, 
improving oxygenation and reducing carbon dioxide.7 
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abstract: Noninvasive ventilation (NIV) and high-flow nasal cannulae therapy (HFNCT) are first-line methods 
of treatment for children presenting with acute respiratory distress, with paediatric intensive care units (PICUs) 
providing an ideal environment for subsequent treatment monitoring. However, the availability of step-down 
units, where NIV and HFNCT can be safely utilised, has reduced the need for such patients to be admitted to 
PICUs, thereby leading to the better overall utilisation of critical care resources. In addition, NIV and HFNCT can 
also be used during transport instead of invasive ventilation, thus avoiding the complications associated with the 
latter approach. This review article examines the safety and applicability of these respiratory support approaches 
outside of paediatric intensive care as well as various factors associated with treatment success or failure.
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امللخ�ص: ُتعترب التهوية غري البا�سعه والعلج بالقنيات الأنفية عالية التدفق من اأ�ساليب العلج الأول للأطفال الذين يعانون من �سائقة 
تنف�سية حادة، حيث توفر وحدات العناية املركزة للأطفال بيئة مثالية ملراقبة العلج لحقا. غري اأن توافر وحدات العناية املتو�سطة حيث 
ميكن ا�ستخدام التهوية غري البا�سعه والعلج بالقنيات الأنفية عالية التدفق باأمان قد قلل من احلاجة اإىل قبول هوؤلء املر�سى يف وحدات 
العناية املركزة للأطفال، مما يوؤدي اإىل ال�ستخدام الكلي الأف�سل ملوارد الرعاية احلرجة. بالإ�سافة اىل ذلك فاإن ا�ستخدام هذه التقنيات 
التنف�سية اأثناء نقل املر�سى بدل من التهوية البا�سعة �ساهم يف جتنب امل�ساعفات املرتبطة بالنهج الأخري. يتناول هذا املقال الأ�ستعرا�سي 
�سلمة واإمكانية تطبيق اأ�ساليب الدعم التنف�سي هذه خارج العناية املركزة للأطفال بالإ�سافة اإىل العوامل املختلفة املرتبطة بنجاح هذا 
العلج اأو ف�سله.
الكلمات املفتاحية: رعاية حرجة؛ اأطفال؛ وحدات العناية املركزة للأطفال؛ تهوية غري با�سعة.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
https://doi.org/10.18295/squmj.2020.20.03.002
Use of Noninvasive Ventilation and High-Flow Nasal Cannulae Therapy for Infants and Children with Acute Respiratory Distress 
Outside of Paediatric Intensive Care 
A review article
e246 | SQU Medical Journal, August 2020, Volume 20, Issue 3
Overall, both NIV and HFNCT are superior to 
invasive ventilation as these methods reduce the risk 
of infection, need for sedation and treatment costs 
associated with the latter approach.1,10
Safety and Efficacy in 
Respiratory Diseases
Variable success rates have been reported in different 
paediatric diseases following NIV. For instance, fav- 
ourable results have been observed with primary 
respiratory diseases including bronchiolitis, asthma 
and pneumonia.4,5 However, NIV has resulted in lower 
success rates among children diagnosed with acute 
respiratory distress syndrome (ARDS).5 In addition, 
patients presenting with multi-organ failure have 
reportedly demonstrated worse outcomes with NIV.5
Similarly, HFNCT is widely used to treat infants 
and children presenting with acute respiratory distress 
and has been successful for various respiratory diseases 
including pneumonia, asthma and obstructive sleep 
apnoea.8,11 According to Kawaguchi et al., HFNCT 
significantly decreased the need for intubation in a 
cohort of patients with mixed respiratory diseases 
(38% versus 63%; P <0.001).11 Other research has also 
shown a decrease in intubation rates following HFNCT 
among infants with severe bronchiolitis (5–9%).12–14 
Nevertheless, a randomised controlled trial (RCT) 
comparing HFNCT to nasal CPAP demonstrated that 
the latter method required less escalation of respiratory 
support and was associated with earlier improvement 
in respiratory distress among a cohort of young infants 
with acute viral bronchiolitis.14 
Application Outside of 
Paediatric Intensive Care
Traditionally, NIV and HFNCT were reserved for 
use in intensive care environments in order to closely 
monitor the development of any technical issues 
or complications and assess the need for further 
treatment.15 However, in recent years, both the 
number of critically ill patients and that of patients 
requiring readmission to intensive care units (ICUs) 
has increased.16–19 These additional demands on 
limited intensive care resources have encouraged 
the application of noninvasive respiratory support 
methods in non-ICU settings including paediatric 
wards, emergency rooms (ERs) and during transport. 
Moreover, the implementation of high-dependency 
or step-down units with the necessary resources to 
safely deliver and monitor respiratory support has also 
assisted in reducing the need for ICU admission.20
emergency rooms and general 
wards
Over the past few years, the use of NIV and HFNCT 
has increased in paediatric wards and ERs.21–23 This is 
because both methods reduce the need for invasive 
ventilation thereby lowering requirements for escal- 
ation to paediatric ICUs (PICUs).2,24 In a recent survey 
conducted across several European countries, 15.5% 
and 20% of participating PICUs reported NIV usage 
in wards and ERs, respectively.25 Moreover, recent 
reports from France and Finland indicate that 
HFNCT is increasingly utilised in paediatric wards in 
hospitals without ICUs with no major adverse events, 
with HFNCT usage outside of the ICU ranging from 
53.3–86.5%.26,27 Table 1 summarises the characteristics 
and outcomes of various studies evaluating the use 
of NIV and HFNCT in paediatric ERs and general 
wards.21–24,28,29 
Franklin et al. conducted a large multicentre RCT 
evaluating the use of HFNCT versus low-flow oxygen 
in 1,472 infants with bronchiolitis managed in a general 
paediatric ward.24 The trial noted that fewer infants in 
the HFNCT group required escalation to intensive 
care compared to those treated with low-flow oxygen 
(12% versus 23%; P <0.001). Moreover, 61% of patients 
in the low-flow oxygen group required HFNCT as a 
rescue treatment, subsequently avoiding the need for 
transfer to the PICU.24 Davison et al. described the 
successful application of HFNCT in an institution 
without an on-site-PICU; however, the researchers 
advised strict observation and treatment monitoring 
and recommended that infants without clinical 
improvement within 60–90 minutes of treatment be 
immediately transferred to a PICU.21
 Various factors have been associated with 
HFNCT failure in general wards and ERs. In a large 
retrospective study of 231 paediatric patients treated 
outside of an ICU, Betters et al. identified underlying 
cardiac disease and increased fraction of inspired 
oxygen requirements to be risk factors for HFNCT 
failure.30 However, the researchers also observed 
that non-responders generally underwent a shorter 
duration of treatment with HFNCT compared to 
responders (median duration: 5.5 versus 28 hours).30 
The use of a treatment protocol to guide the application 
of HFNCT may help to reduce duration of hospital 
stay and treatment costs as well as faster weaning.27,31
In the ER, patients with increased work of breathing 
at presentation, high initial partial pressure of carbon 
dioxide measurements and pH values of <7.3 were 
reportedly more likely to fail HFNCT treatment.28,29 
Moreover, patients who required intubation were 
more likely to have features of impending respiratory 
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failure at their initial assessment.28 In contrast, certain 
respiratory conditions such as bronchiolitis have been 
associated with HFNCT success.28,30
during transport
The popularity of noninvasive respiratory approaches 
during transport has also increased in recent years. The 
European survey reported that 36.4% of participating 
PICUs used NIV during paediatric transport.25 A 
summary of previous research evaluating the use 
of NIV and HFNCT during paediatric transport is 
presented in Table 2.32–38 Unfortunately, all of the 
studies evaluating NIV and HFNCT outcomes during 
transport were observational in nature. Therefore, 
there is a need for RCTs comparing outcomes with 
HFNCT to those of CPAP and other modes of NIV 
during paediatric and neonatal transport.
Schlapbach et al. compared outcomes following 
HFNCT during transport with that of a historical 
cohort transferred prior to the introduction of 
HFNCT.32 Overall, 49% of patients in the pre-HFNCT 
era were intubated during transport compared to 
35% in the period following HFNCT introduction 
(P <0.001). Similarly, NIV utilisation also decreased 
following the introduction of HFNCT (7% versus 2%).32 
In total, 33% of the patients received HFNCT during 
transport in the latter era, with no significant adverse 
events noted, including the need for intubation or 
cardiopulmonary resuscitation.32 Abraham et al. also 
confirmed the safety of HFNCT usage during transfer 
in a retrospective study of 114 infants, although 
23% subsequently required escalation of respiratory 
support following transfer.33
Table 1: Summary of selected studies evaluating the use of noninvasive ventilation and high-flow nasal cannulae 
therapy in paediatric emergency rooms and general wards21–24,28,29
Author and year 
of study
Study design Mode of 
respiratory 
support
Study setting Sample Outcome








wards at 17 
hospitals
1,472 infants aged 
<12 months with 
bronchiolitis
• Fewer infants in the HFNCT 
group required transfer to the 
PICU compared to those in the 
low-flow oxygen group (12% 
versus 23%). 
• Overall, 61% of infants in 
the low-flow oxygen group 
required rescue treatments 
involving HFNCT.













• Two-thirds of the patients 
underwent HFNCT in 
paediatric wards with no 
adverse effects. 
• Only 13% of patients required 
transfer to an off-site PICU.











62 children aged 




• HFNCT was superior to 
low-flow oxygen in improving 
respiratory distress within two 
hours of treatment.








• NIV led to improvements 
in WOB and pulmonary gas 
exchange. 
• In addition, NIV reduced the 
need for PICU transfer.
Kelly et al.28 (2013) Retrospective 
study




• The majority of patients 
were treated successfully 
with HFNCT, with only 8% 
requiring intubation. 
• Most cases of HFNCT failure 
demonstrated features of 
impending respiratory failure 
at triage stage.
Long et al.29 (2016) Prospective 
observational 
study
HFNCT ER 71 patients • The majority of patients 
improved following HFNCT, 
with only 39% requiring 
escalation of respiratory 
support.
RCT = randomised controlled trial; HFNCT = high-flow nasal cannulae therapy; ER = emergency room; PICU = paediatric intensive care unit; 
NIV = noninvasive ventilation; WOB = work of breathing.
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Boyle et al. concluded that HFNCT was a safe 
option for transporting neonates, provided that the 
neonate was stable for 24 hours pre-transfer and 
certain pre-requisites were met concerning age, 
weight and flow at the time of transfer.39 Moreover, the 
researchers noted that HFNCT usage was associated 
Table 2: Summary of selected research evaluating the use of noninvasive ventilation and high-flow nasal cannulae therapy 
during paediatric transport32–38
Author and year 
of study
Study design Mode of 
respiratory support
Sample Outcome






793 infants aged ≤2 years • The frequency of both invasive 
ventilation (49% versus 35%) and 
NIV (7% versus 2%) decreased 
following the introduction of 
HFNCT. 
• Overall, 33% of infants underwent 
HFNCT during transport. 
• No adverse effects were noted 
among those who underwent 
HFNCT during transport. 




HFNCT 114 infants, of which 50% 
had bronchiolitis
• No adverse events were observed 
during transport. 
• The method of respiratory support 
was changed to NIV (CPAP) before 
transport in 3% of patients. 
• Post-transport, 23% of patients 
required escalation of respiratory 
support.




NIV (CPAP) 54 infants with suspected 
bronchiolitis
• No adverse events were noted 
during transport. 
• However, 10% required intubation 





NIV (CPAP) 369 neonates aged ≥32 
gestational weeks with 
acute respiratory distress
• During the two-year study period, 
CPAP use increased from 33% to 
59%. 
• Overall, 13% of the neonates 
required intubation within 24 hours 
of transport, likely due to higher 
initial oxygen requirements. 
• There was no significant morbidity 
or mortality.




NIV (CPAP and 
BPAP)
25 children and 
teenagers aged ≤18 years
• Overall, 64% and 36% of patients 
were transported on CPAP and 
BPAP, respectively. 
• No adverse events were observed 
during transport. 
• However, 35% of patients required 
intubation within 84 hours of 
transport.






NIV (CPAP) or OCN
288 children aged ≤17 
months with acute 
respiratory failure, 
of which 58% had 
bronchiolitis
• Overall, 19%, 37% and 44% of 
patients were transported on 
invasive ventilation, CPAP and 
OCN, respectively. 
• Minor adverse events (i.e. 
intolerance to the interface) were 
observed in 3% of patients. 
• One patient required intubation 
during transport.




NIV (CPAP) and 
HFNCT
858 neonates and 
children
• The rate of minor adverse events 
was 1–4%. 
• Only 0.4% of patients required 
intubation or escalation of support 
during transfer. 
• Overall, 10% needed intubation 
within 24 hours of transfer. 
• The odds of intubation within 
24 hours were higher for patients 
on CPAP compared to those on 
HFNCT.
NIV = noninvasive ventilation; HFNCT = high-flow nasal cannulae therapy; CPAP = continuous positive airway pressure; BPAP = bilevel positive 
airway pressure; OCN = oxygen cannula/nebulisation.
Khaloud S. Almukhaini and Najwa M. Al-Rahbi
Review | e249
with increased comfort for patients, as well as a 
reduction in the need to change the mode of respiratory 
support for the purposes of patient stabilisation 
before transfer.39 Similarly, a large prospective study 
of 288 children with acute respiratory failure found 
that stabilisation occurred more rapidly with NIV 
compared to invasive ventilation (median time: 48 
versus 83 minutes; P <0.001).36 
Other research has also shown that NIV and 
HFNCT usage during transport is safe and feasible and 
reduces the need for invasive ventilation.34,35 Cheema et 
al. noted that the rate of adverse events was low (1–4%) 
in a systematic review of eight observational studies 
evaluating NIV and HFNCT usage during paediatric 
transport.38 Observed side-effects included apnoea 
and the need for cardiopulmonary resuscitation or 
bag mask ventilation. However, only 0.4% required 
intubation or escalation of respiratory support during 
transport, although 10% required intubation within 24 
hours of transfer.38 
Regardless of mode of respiratory support, spec- 
ialised retrieval teams are essential to the safe transfer 
of patients. In an observational study of paediatric 
transfers over a six-month period, Barry and Ralston 
reported that patient retrieval by non-specialised 
teams was linked with complications during transfer.40 
In addition, researchers have noted certain clinical 
contraindications for transporting children on NIV.36,37 
An early study assessing the safety of NIV during 
transport reported no adverse events; however, this 
approach was not considered for children diagnosed 
with shock, cardiopulmonary arrest or trauma to 
the head and neck.36 According to Millán et al., this 
respiratory support approach should be considered 
only in the presence of a well-trained transport team.37 
The authors also recommended the application of 
strict inclusion and exclusion criteria when selecting 
patients. For example, the researchers considered NIV 
usage during transport to be unsuitable for children 
with a diagnosis of ARDS and those requiring high 
NIV settings or demonstrating a lack of clinical 
response to NIV.37
Conclusion
According to the available literature, the application 
of HFNCT or NIV respiratory approaches in non-
intensive care environments seems to be safe and 
feasible, provided that continuous monitoring and 
specialised staff are available. In addition, institutional 
protocols for the early evaluation of children with 
acute respiratory distress may be useful to determine 
the necessity for further escalation of therapy or PICU 
transfer.
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